Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Invizius, a UK-based University of Edinburgh spinout commercialising anti-inflammatory coatings for medical devices, has obtained £2.8m ($3.4m) in a round involving the university’s Old College Capital and the government-owned Scottish Investment Bank. The round was led by Mercia Asset Management and also featured Downing Ventures. It will go towards pre-clinical work and production of Invizius’s…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.